March 3rd, 2021 - Press notes
Article published in Nutrients
A study by physicians and researchers at Hospital del Mar, the Hospital del Mar Medical Research Institute and Pompeu Fabra University has shown that patients infected with SARS-CoV-2 coronavirus with lower blood zinc levels require a longer recovery time and are at higher risk of death. Mortality in this patient group was 21% compared to 5% of those with higher levels of zinc in the blood. At the same time, the study has carried out in vitro tests which demonstrated the protective effect of this element by limiting the spread of the coronavirus in human cells. The researchers draw attention to the benefits of zinc supplementation for patients with covid-19 to speed up their recovery and to risk groups to limit the severity of its effects. The study has just been published in the journal Nutrients and was one of the highlights of the European Society of Clinical Microbiology and Infectious Diseases' conference on covid-19.12th February 2021 - Press notes
The Hospital del Mar is the promoter of the Phase 2 study that will assess the antiviral efficacy of compound E-52862, produced by ESTEVE, in the early treatment of outpatients with mild COVID-19 symptoms.
2 February, 2021 - Press notes
The worsened mental health and mood of elderly people at risk of developing dementia, caused by the lockdown measures, was prolonged during the early weeks of de-escalation. The study, led by researchers from the Hospital del Mar Medical Research Institute and doctors from Hospital del Mar, in collaboration with the Barcelona βeta Brain Research Center, a research centre affiliated with the Pasqual Maragall Foundation, has been published in the Journal of Alzheimer's Disease. New technologies were used to monitor the participants and understand the impact of lockdown. The people who took part are part of the PIENSA study on the prevention of cognitive deterioration in stages prior to the onset of dementia.
16 December 2020 - Press notes
This work is a collaboration between Núria López-Bigas' lab at IRB Barcelona and the groups headed by Anna Bigas (Hospital del Mar Medical Research Institute) and Josep Maria Ribera (Josep Carreras Leukaemia Research Institute). The results have been published in Genome Biology.
December 2nd, 2020 - Press notes
In an article published in the journal World Psychiatry, leading experts in this field recommend the approach implemented in the Barcelona centre. One of the authors of the article is Dr. Marta Torrens, Director of the Addiction Process group in the Neuropsychiatry and Addictions Institute at Hospital del Mar. Patients with a dual diagnosis are those who suffer an addiction to a substance of abuse in addition to another psychiatric disorder. The authors of the article advise authorities and organisations to adopt a multidisciplinary approach that will allow an early diagnosis of this comorbidity, and to pay particular attention to minors living with these patients.
27th November 2020 - Press notes
The MAPBM (Maturity Assessment Model for Patient Blood Management) project makes it easier for hospitals to adjust transfusions and is the key to properly managing hospital blood reserves at a time when donations are falling sharply as a result of measures to prevent the spread of COVID-19. In five years, this project, promoted by the Hospital del Mar Medical Research Institute, has already reached around sixty hospitals in Spain. This success demonstrates the feasibility of implementing the model and making it a tool for improving both patient safety and outcomes, according to a study just published in the journal Blood Transfusion. Hospital del Mar stands out in this field and has been awarded at the annual meeting of the hospitals participating in the project as the center without cardiac surgery with the best results.
3rd November 2020 - Press notes
A joint study by physicians at Hospital del Mar, researchers from the Hospital del Mar Medical Research Institute, Pompeu Fabra University and the Pere Virgili Health Care Park suggests that certain drugs used to treat this condition are safe for COVID-19 patients and could even have a protective effect. The results support the recommendations of the scientific guidelines relating to the desirability of maintaining treatments for osteoporosis in patients with COVID-19. This is the first study of its kind in the world. It has just been published in the journal Aging.
8th October, 2020 - Press notes
A study by researchers from Hospital del Mar and the Hospital del Mar Medical Research Institute reveals the protective effect that 30 minutes of moderate physical activity per day can have, as recommended by the World Health Organisation. Multiplying this figure by four maximises the benefit, but, beyond this, there is no additional benefit. The study, published by the Revista Española de Cardiología (Spanish Journal of Cardiology), has been monitoring over 11,000 people for more than 7 years.
October 2nd, 2020 - Press notes
Benign breast diseases (BBD), which are non-cancerous disorders of the breast, such as lumps, are known to increase the chances of subsequent breast cancer. Now a team of Hospital del Mar researchers have found that the way BBD is detected as part of a national screening programme is an indication of which are more likely to become cancerous.
15/09/2020 - Press notes
This discovery may provide new treatment strategies and therapeutic targets for important diseases such as cancer or Alzheimer's
The research group of GPCR Drug Discovery at the Hospital del Mar Medical Research Institute (IMIM), in collaboration with the Indian Institute of Technology in Kanpur, has deciphered how nature adjusts the response of the human cell to abundant extracellular stimuli (e.g., smell, taste, light, hormones, etc.).Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2025 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility
